Treatment at accredited hospitals improves outcomes for colon cancer patients

A retrospective study involving 222,583 colon cancer patients highlights the impact of Commission on Cancer (CoC) hospital accreditation on treatment quality and survival. At CoC-accredited facilities, 91.2% of patients received guideline-concordant lymphadenectomy and 81.9% received appropriate chemotherapy. Notably, risk-adjusted mortality rates were significantly reduced across all stages of disease. The findings underscore the importance of accredited hospitals in delivering quality cancer care and improving patient outcomes.